|
Originally published In Press as doi:10.1074/jbc.M200191200 on April 30, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24243-24251, July 5, 2002
Novel Mode of Interference with Nuclear Factor of Activated
T-cells Regulation in T-cells by the Bacterial Metabolite
n-Butyrate*
Christos
Diakos ,
Eva E.
Prieschl§,
Marcus
Säemann ,
Veronica
Novotny§,
Georg
Böhmig¶,
Robert
Csonga§,
Thomas
Baumruker§, and
Gerhard J.
Zlabinger
From the Institute of Immunology, University of
Vienna, Borschkegasse 8a, A-1090 Vienna, the § Department of
Allergic Diseases, Novartis Research Institute, Brunnerstrasse 53,
A-1235 Vienna, and the ¶ Department of Internal Medicine III,
Division of Nephrology, University of Vienna, Währinger
Gürtel 18-20, A-1090 Vienna, Austria
The transcription factor nuclear factor of
activated T-cells (NF-AT) plays an essential role in the activation of
many early immune response genes. A dynamic equilibrium between
calcineurin and cellular kinases controls its phosphorylation and thus
regulates its activity by determining its subcellular localization.
Here, we demonstrate that T-cell activation in the presence of the
bacterial metabolite n-butyrate, which leads to inhibition
of interleukin-2 transcription, is characterized by the maintenance of
the activity of counter-regulatory kinases glycogen synthase kinase 3 and protein kinase A as well as persistence of intracellular cAMP
levels, whereas calcium response and mitogen-activated protein kinase activation were indistinguishable from cells stimulated in the absence
of n-butyrate. Nuclear binding of NF-AT was decreased but
other transcription factors implicated in interleukin-2 expression such
as AP1 and nuclear factor B were unaffected. The effect on NF-AT
binding appeared to be the result of increased nuclear export because
the export inhibitor leptomycin B completely restored nuclear binding
of NF-AT. We, therefore, provide first evidence for interference with
NF-AT regulation alternative to the currently understood inhibition of
nuclear import. This mechanism might represent a bacterial strategy to
subvert host defense, which could be of particular clinical importance
in the gastrointestinal tract where high amounts of
n-butyrate are physiologically present.
*
This work was supported by Austrian Research Fund Grant P
14874-PAT.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
43-1-4277-64971; Fax: 43-1-4277-64972; E-mail:
gerhard.zlabinger@univie.ac.at.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Bosisio, M. Vulcano, A. Del Prete, M. Sironi, V. Salvi, L. Salogni, E. Riboldi, F. Leoni, C. A. Dinarello, G. Girolomoni, et al.
Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1540 - 1548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Nakamura, I. Matsushita, E. Kosaka, T. Kondo, and T. Kimura
Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells
Rheumatology,
April 1, 2008;
47(4):
418 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakamura, T. Kukita, T. Shobuike, K. Nagata, Z. Wu, K. Ogawa, T. Hotokebuchi, O. Kohashi, and A. Kukita
Inhibition of Histone Deacetylase Suppresses Osteoclastogenesis and Bone Destruction by Inducing IFN-{beta} Production
J. Immunol.,
November 1, 2005;
175(9):
5809 - 5816.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|